Regenerative medicine, while not a new area of medical research, has advanced within the last several years to emerge as one of the best hopes for addressing, and even curing, diseases that until now had few or no treatment options. These regenerative methods have far-reaching potential and mark an important next wave of research into targeting genetically defined diseases, as well as chronic or life-threatening disorders that are underserved or not yet addressed.
These untapped market opportunities provide for an active deal-making environment around these assets, and there is great investor interest in...